Mediwound (NASDAQ:MDWD) and Aurora Cannabis (NYSE:ACB) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.
This is a breakdown of current recommendations and price targets for Mediwound and Aurora Cannabis, as reported by MarketBeat.
Mediwound currently has a consensus price target of $13.00, indicating a potential upside of 173.68%. Aurora Cannabis has a consensus price target of $9.50, indicating a potential upside of 32.50%. Given Mediwound’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Mediwound is more favorable than Aurora Cannabis.
Earnings and Valuation
This table compares Mediwound and Aurora Cannabis’ top-line revenue, earnings per share and valuation.
Aurora Cannabis has